Jay Lichter

JANX

Jay Lichter serves as an insider at Janux Therapeutics, Inc. (JANX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$82.30M

Net Position

Net Seller

$82.30M

Companies Traded

JANX

Active Period

Jun 2024 – Oct 2024

2 total trades

Most Recent

Sell JANX

Oct 24, 2024 · $178.1K

Jay Lichter's Insider Trading at Janux Therapeutics, Inc. (JANX)

Buys

0 · $0.00

Sells

2 · $82.30M

Total Shares Bought

Total Shares Sold

1,503,815

JANX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Oct 24, 2024	Sell	3,815	$46.68	$178.1K	7,000
Jun 5, 2024	Sell	1,500,000	$54.75	$82.13M	3,340,018

Related Insiders

Janeen Noel Doyle

officer: Chief Corp. & Bus. Dev. Ofcr

JANXSell · Jun 4, 2026

Maria Dobek

Vice President, Accounting

JANXSell · May 13, 2026

Thomas DiRaimondo

Chief Scientific Officer

JANXSell · Jan 2, 2026

David Alan Campbell

President and CEO

JANXSell · Jan 2, 2026

Zachariah McIver

Chief Medical Officer

JANXSell · Jan 2, 2026

Andrew Hollman Meyer

Chief Business Officer

JANXSell · Jan 2, 2026

Charles M. Winter

Chief Technical Officer

JANXSell · Jan 2, 2026

Explore More Insider Trading Data

JANX Insider Trading Activity

View all insider trades at Janux Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity